Business Wire

Leclanché Selected by KONGSBERG to Power the Fast Growing Electric and Hybrid Marine Industry with Energy Storage Solutions

Jaa

Leading global maritime technology company Kongsberg Maritime has selected Leclanché, one of the world’s leading storage solutions companies, as its battery partner and supplier of customised marine energy storage solutions. The partnership contributes to KONGSBERG’s new generation of hybrid power solutions, which are set to deliver game-changing efficiencies and reduce the environmental impact of transportation with cutting-edge autonomous and crewed vessel newbuilds.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181111005050/en/

Leclanché’s batteries will be an integral part of KONGBSERG’s hybrid solutions. Through the partnership, Leclanché will deliver one of the largest single marine battery system order to date for 9 vessels totalling 45MWh batteries. The systems will be built at Leclanché’s facility in Switzerland with the cells manufactured at Leclanché’s Willstätt facility in Germany.

  • The first project to be jointly executed will be Yara Birkeland, the world’s first autonomous and electric container vessel with zero emissions ordered by YARA, one of the world’s leading fertilizer companies and a provider of environmental solutions. Replacing 40,000 truck journeys a year, Yara Birkeland will eliminate NOx and CO2 emissions and improve road safety, whilst also reducing noise and dust emissions currently caused by trucks in a densely populated urban area. https://www.youtube.com/watch?v=tFH595gytSE
  • The second project relates to vessels known as Grimaldi Green 5th Generation (GG5G). Grimaldi is one of the world’s largest operators of Roll-on/ Roll-off (Ro-Ro) and Roll-on/ Roll-off Passenger (Ro-Pax) vessels. The hybrid propulsion system delivered by Kongsberg includes supply and integration of shaft generators, frequency drives, energy management systems together with Leclanché battery systems. The GG5Gs will be the first in a new series of hybrid Ro-Ro vessels using fossil fuel during navigation, with batteries providing a peak-shaving function and electricity in port.

The new partnership with KONGSBERG underscores Leclanché’s strategy of being a vertically integrated system supplier to growth markets such as merchant marine and fleet transportation, moving beyond being a ‘pure play’ cell producer. Leclanché made an early investment in developing a DNV GL certified battery system for marine applications, and is the first battery supplier to fully comply with the stringent 2015 regulations that are currently in force. DNV GL is an international accredited registrar and classification society for maritime vessels headquartered in Høvik, Norway.

Frode Kaland, EVP Supply Chain for Kongsberg Maritime said: “Leclanché’s ability to cover the complete value chain from design and production of lithium cells in Europe, to full battery systems certified for marine applications together with our proprietary hybrid power technology positions us together as a single, unified supplier of electrification solutions that will deliver lower operational expenditure and enable environmental sustainability for all vessel types”.

Anil Srivastava, CEO of Leclanché said: "The partnership between Kongsberg Maritime, one of the world’s leading providers of electrification solutions to the maritime industry and Leclanché has the potential to be game changing as it brings low and zero-emission solutions to the sizeable and fast growing electric and hybrid marine market. Leclanché’s focus on maritime is an essential component of our focus on the electrification of fleets and maritime is ideally suited to both our superior battery systems and our partnership approach to deliver emissions busting solutions. We are seeing a paradigm shift in the maritime industry towards electric power and partnerships with world class industry leaders such as KONGSBERG further demonstrate that Leclanché’s opportunity is now."

* * * * *

About Kongsberg

KONGSBERG (OSE-ticker: KOG) is an international, knowledge-based group delivering high technology systems and solutions to clients within the oil and gas industry, merchant marine, defence and aerospace. KONGSBERG has 7 000 employees located in more than 25 countries and total revenues of NOK 14.5 billion in 2017. Follow us on Twitter: @kongsbergasa. kongsberg.com

Kongsberg Maritime (KM) is the largest division of KONGSBERG and a world-leader in the development and delivery of integrated vessel concepts for traditional merchant vessels and fishing vessels, as well as offshore and research vessels and offshore installations.

The maritime industry is entering a new era, and Kongsberg Maritime is at the forefront of these changes.

About Leclanché

Headquartered in Switzerland, Leclanché SA is a leading provider of high quality energy storage solutions designed to accelerate our progress towards a clean energy future. Leclanché’s history and heritage is rooted in over 100 years of battery and energy storage innovation and the Company is a trusted provider of energy storage solutions globally. This coupled with the Company’s culture of German engineering and Swiss precision and quality, continues to make Leclanché the partner of choice for both disruptors, established companies and governments who are pioneering positive changes in how energy is produced, distributed and consumed around the world. The energy transition is being driven primarily by changes in the management of our electricity networks and the electrification of transport, and these two end markets form the backbone of our strategy and business model. Leclanché is at the heart of the convergence of the electrification of transport and the changes in the distribution network. Leclanché is the only listed pure play energy storage company in the world, organised along three business units: stationary storage solutions, etransport solutions and specialty batteries systems. Leclanché is listed on the Swiss Stock Exchange (SIX: LECN). Leclanche.com

SIX Swiss Exchange: ticker symbol LECN | ISIN CH 011 030 311 9

Disclaimer

This press release contains certain forward-looking statements relating to Leclanché's business, which can be identified by terminology such as "strategic", "proposes", "to introduce", "will", "planned", "expected", "commitment", "expects", "set", "preparing", "plans", "estimates", "aims", "would", "potential", "awaiting", "estimated", "proposal", or similar expressions, or by expressed or implied discussions regarding the ramp up of Leclanché's production capacity, potential applications for existing products, or regarding potential future revenues from any such products, or potential future sales or earnings of Leclanché or any of its business units.

You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Leclanché regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Leclanché's products will achieve any particular revenue levels. Nor can there be any guarantee that Leclanché, or any of the business units, will achieve any particular financial results.

* * * * *

Contact information

Kongsberg contact :
Gunvor Hatling Midtbø
T : + 47 99214209
E-mail : ghm@konsgberg.com
or
Leclanché contacts
Media contacts
Europe/global :
Desiree Maghoo
T : +44 (0) 7775 522 740
E-mail : dmaghoo@questorconsulting.com
or
Thomas Balmer
T : +41 (0) 79 703 87 28
E-mail : tba@dynamicsgroup.ch
or
Laure Lagrange
T : +44 (0) 7768 698 731
E-mail : llagrange@questorconsulting.com
or
US and Canada :
Rick Anderson
T : +1-718-986-1596
or
Henry Feintuch
T : +1-212-808-4901
E-mail: Leclanché@feintuchpr.com
Switzerland :
Thierry Meyer
T : +41 (0) 79 785 35 81
E-mail : tme@dynamicsgroup.ch
or
Investor Contacts :
Anil Srivastava / Hubert Angleys
T : +41 (0) 24 424 65 00
E-mail : invest.Leclanché@Leclanché.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 10:00:00 EESTTiedote

Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 21:20:00 EESTTiedote

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 17:00:00 EESTTiedote

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 13:20:00 EESTTiedote

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 08:00:00 EESTTiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 04:00:00 EESTTiedote

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme